Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Anika, Electrocore, Intravent, Quanterix.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: ADC, Alnylam, Beigene, Chiesi, Hummingbird, Hutchmed, Instil, Mirum, Monopar, Redhill, Relief, Scynexis, Tonix, Y-Mabs.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Visby Medical.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Diacarta.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Cantargia, Mirror.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Madorra, Vonco Products.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Aim Immunotech, Albireo, Ascendis, Azurrx, Benitec, Biocryst, Boehringer, Clover, Decibel, Eli Lilly, Eloxx, Freeline, GNT, Hibercell, Humanigen, Inflarx, Myovant, Nabriva, Pfizer, Phathom, Sigilon, Sinovac, Sinovant, Soin, Soligenix, Tearclear, Viewpoint, Vor.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Intelivation, Johnson & Johnson Vision, Joimax, Neuroone, Royal Biologics.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Alpha Cognition, Ascletis, Biomarin, Cormedix, Gensight, Global Blood, JW, Merck & Co., Moderna, RDIF, Underdog, Versantis.

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Advaccine, Beigene, Biontech, Coherus, Cstone, Eli Lilly, Entos, Eqrx, Gloria, Harbour, Huya, Innocare, Inovio, Junshi, Ligand, Moderna, Neuren, Pfizer, Suzhou Genhouse.